Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 129 100 KRW 0.08% Market Closed
Market Cap: 1.5T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Income Statement

Earnings Waterfall
Daewoong Pharma

Revenue
1.4T KRW
Cost of Revenue
-691B KRW
Gross Profit
725.7B KRW
Operating Expenses
-587.7B KRW
Operating Income
137.9B KRW
Other Expenses
-34.4B KRW
Net Income
103.6B KRW

Income Statement
Daewoong Pharma

Rotate your device to view
Income Statement
Currency: KRW
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
734 716
N/A
735 889
+0%
758 475
+3%
778 975
+3%
812 337
+4%
839 686
+3%
857 252
+2%
869 025
+1%
862 689
-1%
883 920
+2%
898 632
+2%
927 951
+3%
959 672
+3%
960 307
+0%
973 799
+1%
990 152
+2%
995 896
+1%
1 031 427
+4%
1 055 676
+2%
1 086 724
+3%
1 098 179
+1%
1 113 426
+1%
1 107 157
-1%
1 068 432
-3%
1 075 830
+1%
1 055 424
-2%
1 067 635
+1%
1 103 386
+3%
1 117 201
+1%
1 152 976
+3%
1 181 714
+2%
1 214 081
+3%
1 255 325
+3%
1 280 092
+2%
1 304 151
+2%
1 332 284
+2%
1 341 290
+1%
1 375 329
+3%
1 388 699
+1%
1 399 052
+1%
1 416 626
+1%
Gross Profit
Cost of Revenue
(461 788)
(465 702)
(485 379)
(505 166)
(534 268)
(537 083)
(534 868)
(522 535)
(498 684)
(510 232)
(520 519)
(541 486)
(557 283)
(553 325)
(563 015)
(578 937)
(592 845)
(621 485)
(631 009)
(635 624)
(628 430)
(635 132)
(627 798)
(612 242)
(629 522)
(608 482)
(604 487)
(610 706)
(599 663)
(608 403)
(622 105)
(627 969)
(635 304)
(641 134)
(649 782)
(657 910)
(670 624)
(687 162)
(688 506)
(690 765)
(690 962)
Gross Profit
272 929
N/A
270 187
-1%
273 097
+1%
273 809
+0%
278 070
+2%
302 603
+9%
322 384
+7%
346 490
+7%
364 003
+5%
373 688
+3%
378 112
+1%
386 464
+2%
402 389
+4%
406 982
+1%
410 785
+1%
411 216
+0%
403 052
-2%
409 943
+2%
424 667
+4%
451 101
+6%
469 751
+4%
478 293
+2%
479 362
+0%
456 192
-5%
446 310
-2%
446 942
+0%
463 149
+4%
492 682
+6%
517 539
+5%
544 573
+5%
559 610
+3%
586 112
+5%
620 021
+6%
638 958
+3%
654 369
+2%
674 373
+3%
670 666
-1%
688 167
+3%
700 194
+2%
708 287
+1%
725 664
+2%
Operating Income
Operating Expenses
(217 029)
(218 243)
(223 614)
(225 605)
(233 939)
(259 039)
(287 553)
(322 275)
(345 896)
(347 794)
(350 722)
(354 844)
(360 668)
(368 026)
(374 753)
(375 314)
(373 512)
(385 377)
(407 935)
(419 128)
(438 767)
(433 606)
(441 735)
(444 539)
(434 948)
(429 962)
(429 180)
(436 785)
(444 849)
(455 844)
(470 216)
(485 388)
(511 911)
(543 160)
(557 146)
(567 127)
(564 137)
(565 575)
(572 415)
(578 251)
(587 733)
Selling, General & Administrative
(191 618)
(194 727)
(199 620)
(204 018)
(209 625)
(220 747)
(227 859)
(240 400)
(245 353)
(234 982)
(238 438)
(237 733)
(240 667)
(251 511)
(250 435)
(253 814)
(253 574)
(262 206)
(272 495)
(285 442)
(306 704)
(316 079)
(326 737)
(325 823)
(312 194)
(307 437)
(298 932)
(303 584)
(311 740)
(321 936)
(331 141)
(341 162)
(358 085)
(373 502)
(380 420)
(387 975)
(383 984)
(387 385)
(396 864)
(399 549)
(407 972)
Research & Development
(20 823)
(18 743)
(17 819)
(15 270)
(17 128)
(31 068)
(51 711)
(73 045)
(91 898)
(103 691)
(103 120)
(106 849)
(111 735)
(107 939)
(113 572)
(112 330)
(109 109)
(113 812)
(110 988)
(111 093)
(110 485)
(109 441)
(107 536)
(111 557)
(115 678)
(115 218)
(122 936)
(125 982)
(126 287)
(127 269)
(132 725)
(137 991)
(147 550)
(163 602)
(170 379)
(172 737)
(173 689)
(171 573)
(168 094)
(170 305)
(170 432)
Depreciation & Amortization
(4 589)
(4 774)
(5 090)
(5 231)
(6 369)
(7 224)
(7 982)
(8 828)
(8 643)
(9 121)
(9 164)
(9 026)
(8 268)
(8 576)
(8 353)
(9 170)
(10 830)
(9 359)
(9 345)
(8 550)
(7 533)
(8 087)
(7 464)
(7 160)
(7 077)
(7 307)
(7 312)
(7 219)
(6 822)
(6 638)
(6 350)
(6 236)
(6 276)
(6 057)
(6 348)
(6 415)
(6 465)
(6 616)
(7 457)
(8 397)
(9 329)
Other Operating Expenses
0
0
(1 085)
(1 086)
(817)
0
0
0
0
0
0
(1 236)
0
0
(2 393)
0
0
0
(15 107)
(14 043)
(14 045)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
55 900
N/A
51 944
-7%
49 483
-5%
48 205
-3%
44 132
-8%
43 564
-1%
34 832
-20%
24 216
-30%
18 109
-25%
25 894
+43%
27 390
+6%
31 620
+15%
41 720
+32%
38 957
-7%
36 031
-8%
35 901
0%
29 538
-18%
24 566
-17%
16 730
-32%
31 971
+91%
30 983
-3%
44 688
+44%
37 626
-16%
11 652
-69%
11 360
-3%
16 980
+49%
33 968
+100%
55 896
+65%
72 689
+30%
88 729
+22%
89 394
+1%
100 724
+13%
108 110
+7%
95 797
-11%
97 222
+1%
107 246
+10%
106 528
-1%
122 592
+15%
127 779
+4%
130 037
+2%
137 931
+6%
Pre-Tax Income
Interest Income Expense
78
2 028
2 417
1 998
1 653
896
(206)
(609)
(2 417)
(1 771)
(4 219)
(4 733)
(4 121)
(9 542)
(8 401)
(6 809)
(8 469)
(6 475)
(5 321)
(6 724)
(4 058)
(5 226)
(5 064)
(993)
(1 749)
8 124
10 372
5 006
4 377
7 923
(1 799)
(4 639)
(168)
(4 694)
(5 199)
(2 172)
(9 650)
(17 239)
(20 103)
(12 614)
(595)
Non-Reccuring Items
(269)
(1 084)
0
0
0
(17)
(24)
(37)
(170)
(1 245)
(1 251)
0
(1 178)
(2 406)
0
(3 457)
(3 383)
(15 107)
0
0
0
(9 317)
0
0
0
(8 988)
0
0
0
(2 310)
0
0
0
(5 219)
0
0
0
29 464
0
0
0
Gain/Loss on Disposition of Assets
(43)
(75)
(80)
(242)
(168)
(764)
(813)
(699)
(497)
(81)
(35)
(138)
72
271
280
(890)
(1 170)
(9 238)
0
0
0
(17)
0
0
0
(720)
0
0
0
(1 029)
0
0
0
246
0
0
0
(1 221)
0
0
0
Total Other Income
968
873
1 170
1 098
4 711
4 072
3 777
4 590
5 359
4 813
4 464
8 689
8 051
8 853
9 759
5 882
6 429
5 632
(6 107)
(14 556)
(16 231)
(6 806)
(15 781)
(15 057)
(15 405)
(1 837)
(62 701)
(57 712)
(60 878)
(73 553)
(19 631)
(18 532)
(19 591)
(47 801)
(52 788)
(55 194)
(53 865)
(11 596)
4 240
(12 423)
(26 747)
Pre-Tax Income
56 633
N/A
53 685
-5%
52 990
-1%
51 058
-4%
50 327
-1%
47 751
-5%
37 565
-21%
27 460
-27%
20 384
-26%
27 609
+35%
26 348
-5%
35 438
+34%
44 543
+26%
36 133
-19%
37 670
+4%
30 627
-19%
22 946
-25%
(623)
N/A
5 302
N/A
10 691
+102%
10 694
+0%
23 322
+118%
16 781
-28%
(4 398)
N/A
(5 794)
-32%
13 559
N/A
(18 361)
N/A
3 191
N/A
16 189
+407%
19 761
+22%
67 963
+244%
77 553
+14%
88 351
+14%
38 330
-57%
39 235
+2%
49 880
+27%
43 013
-14%
121 999
+184%
111 916
-8%
105 000
-6%
110 589
+5%
Net Income
Tax Provision
(26 455)
(23 215)
(23 376)
(23 405)
(9 130)
(12 078)
(9 792)
(7 372)
(5 038)
(1 483)
(1 521)
(4 465)
(5 871)
(696)
(1 164)
1 440
3 146
(14 795)
(15 987)
(17 145)
(16 300)
5 544
7 432
14 227
13 523
10 589
18 625
9 564
5 223
10 323
(3 742)
(6 055)
(7 620)
834
611
2 482
3 399
(1 996)
2 224
(20 934)
(13 508)
Income from Continuing Operations
30 179
30 470
29 613
27 651
41 196
35 674
27 773
20 089
15 346
26 126
24 827
30 973
38 672
35 436
36 507
32 068
26 094
(15 417)
(10 685)
(6 454)
(5 607)
28 866
24 214
9 829
7 728
24 148
261
12 753
21 412
30 084
64 221
71 498
80 731
39 163
39 846
52 362
46 412
120 003
114 141
84 066
97 081
Income to Minority Interest
997
1 075
942
925
3 462
7 256
6 640
5 932
4 357
844
2 605
3 480
645
(3 856)
(5 430)
(6 773)
(6 484)
265
(1 395)
140
(2 414)
(6 860)
(7 385)
(12 309)
(9 385)
(11 395)
(11 291)
(9 782)
(9 873)
(5 578)
(2 835)
1 233
1 532
3 076
4 184
(1 058)
(31)
1 736
334
6 807
6 492
Net Income (Common)
31 177
N/A
31 544
+1%
30 556
-3%
28 577
-6%
44 658
+56%
42 930
-4%
34 414
-20%
26 022
-24%
19 705
-24%
26 970
+37%
27 433
+2%
34 454
+26%
39 318
+14%
31 581
-20%
31 077
-2%
25 296
-19%
19 610
-22%
(15 152)
N/A
(12 078)
+20%
(6 313)
+48%
(8 020)
-27%
22 006
N/A
16 828
-24%
(2 481)
N/A
(1 658)
+33%
12 753
N/A
(11 030)
N/A
2 971
N/A
11 539
+288%
24 506
+112%
61 386
+150%
72 731
+18%
82 263
+13%
42 240
-49%
44 030
+4%
51 305
+17%
46 381
-10%
121 739
+162%
114 474
-6%
90 872
-21%
103 573
+14%
EPS (Diluted)
3 117.7
N/A
3 154.4
+1%
3 055.6
-3%
2 857.7
-6%
4 465.8
+56%
4 293
-4%
3 441.4
-20%
2 602.19
-24%
1 970.5
-24%
2 697
+37%
2 743.3
+2%
3 445.4
+26%
3 931.8
+14%
3 158.1
-20%
3 107.7
-2%
2 529.6
-19%
1 961
-22%
-1 515.2
N/A
-1 207.8
+20%
-631.29
+48%
-802
-27%
2 200.6
N/A
1 682.8
-24%
-225.54
N/A
-150.72
+33%
1 159.36
N/A
-1 002.72
N/A
268.38
N/A
1 042.4
+288%
2 226.87
+114%
5 544.22
+149%
6 570.6
+19%
7 431.67
+13%
3 815.95
-49%
3 939.68
+3%
4 458.83
+13%
4 030.93
-10%
10 656.06
+164%
9 948.85
-7%
7 897.63
-21%
9 001.48
+14%

See Also

Discover More